Hua Medicine Company

Hua Medicine is a clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. Founded by pharma industry veterans and funded by a premier group of international VC investment firms such as Fidelity Asia, Fidelity Biosciences, ARCH Ventures, Venrock, SAIL and WuXi Ventures, the company has in-licensed from major pharma, world-wide rights to a potential best-in-class, oral drug for the treatment of Type 2 Diabetes which utilizes a novel mechanism of action.
Technology: Small Molecules
Industry: PharmTech
Headquarters: Shanghai, Shanghai, China
Zip: 101-250
Founded Date: 2010-01-01
Employees Number: 101-250
Funding Status: IPO
Acquisitions Number: 20
Investors Number: 242400000
Total Funding: Less than $1M
Estimated Revenue: 2018-09-13
Last Funding Date: Series E
Last Funding Type:

Visit Website
Register and Claim Ownership